DK0517820T3 - Anvendelse af 3-guanidinopropionsyre ved fremstillingen af et lægemiddel til behandling og hindring af overdreven fedme - Google Patents

Anvendelse af 3-guanidinopropionsyre ved fremstillingen af et lægemiddel til behandling og hindring af overdreven fedme

Info

Publication number
DK0517820T3
DK0517820T3 DK91905921.2T DK91905921T DK0517820T3 DK 0517820 T3 DK0517820 T3 DK 0517820T3 DK 91905921 T DK91905921 T DK 91905921T DK 0517820 T3 DK0517820 T3 DK 0517820T3
Authority
DK
Denmark
Prior art keywords
medicament
prevention
manufacture
treatment
guanidinopropionic acid
Prior art date
Application number
DK91905921.2T
Other languages
Danish (da)
English (en)
Inventor
Martin Durham Meglasson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0517820T3 publication Critical patent/DK0517820T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK91905921.2T 1990-02-28 1991-02-27 Anvendelse af 3-guanidinopropionsyre ved fremstillingen af et lægemiddel til behandling og hindring af overdreven fedme DK0517820T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48661590A 1990-02-28 1990-02-28
PCT/US1991/000334 WO1991012799A1 (en) 1990-02-28 1991-01-22 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders

Publications (1)

Publication Number Publication Date
DK0517820T3 true DK0517820T3 (da) 1997-06-09

Family

ID=26782896

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91905921.2T DK0517820T3 (da) 1990-02-28 1991-02-27 Anvendelse af 3-guanidinopropionsyre ved fremstillingen af et lægemiddel til behandling og hindring af overdreven fedme

Country Status (14)

Country Link
US (2) US5132324A (enExample)
EP (2) EP0517820B1 (enExample)
JP (2) JPH0825875B2 (enExample)
KR (1) KR100190257B1 (enExample)
AT (1) ATE141505T1 (enExample)
AU (2) AU7316591A (enExample)
CA (1) CA2073873C (enExample)
DE (1) DE69121561T2 (enExample)
DK (1) DK0517820T3 (enExample)
ES (1) ES2090317T3 (enExample)
GR (1) GR3021424T3 (enExample)
NZ (2) NZ245541A (enExample)
WO (2) WO1991012799A1 (enExample)
ZA (1) ZA911496B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356913A (en) * 1990-02-09 1994-10-18 The Upjohn Company Use of insulin sensitizing agents to treat hypertension
WO1993003724A1 (en) * 1991-08-26 1993-03-04 The Upjohn Company Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
US6008253A (en) * 1991-08-26 1999-12-28 The Upjohn Company Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal
EP0600973A1 (en) * 1991-08-27 1994-06-15 The Upjohn Company A method for treatment of metabolic disorders and metabolism
AU6950294A (en) * 1993-05-14 1994-12-12 Amira, Inc. Treating body parts susceptible to ischemia using creatine analogs
US5808246A (en) * 1995-09-25 1998-09-15 Otis Elevator Company Triac drive for three-phase line-powered linear induction motor elevator door operator
WO1997013507A1 (en) * 1995-10-11 1997-04-17 Avicena Group, Inc. Use of creatine analogues for the treatment of disorders of glucose metabolism
JP2000502667A (ja) * 1995-12-22 2000-03-07 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Ｎｉｄｄｍの治療のためのアミノグアニジン
DE19622222A1 (de) * 1996-06-03 1997-12-04 Hoechst Ag Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
US20040122096A1 (en) * 1996-06-03 2004-06-24 Hoechst Aktiengesellschaft Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for preparing a medicament for normalizing serum lipids
WO1998035667A1 (en) * 1997-02-13 1998-08-20 Smithkline Beecham Plc Use of nitric oxid synthase inhibitors for the treatment of diabetes
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
EP1108434B1 (en) 1998-08-24 2014-05-14 Kurokawa, Kiyoshi Drugs for relieving carbonyl stress and peritoneal dialysates
US7014307B2 (en) * 1998-11-09 2006-03-21 Silverbrook Research Pty Ltd Printing unit for an image recordal and generation apparatus
US20050027005A1 (en) * 2003-08-02 2005-02-03 Matthias Boldt Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner
US8506934B2 (en) * 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
WO2006119292A2 (en) * 2005-04-29 2006-11-09 Henkin, Robert Methods for detection of biological substances
JP4777225B2 (ja) * 2006-12-04 2011-09-21 キヤノン株式会社 吐出用液体及び吐出方法
US8293489B2 (en) 2007-01-31 2012-10-23 Henkin Robert I Methods for detection of biological substances
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
WO2012138214A1 (en) * 2011-04-08 2012-10-11 Brewster Lizzy Maritza Beta-guanidinopropionic acid for the treatment of hypertension
WO2015126944A1 (en) 2014-02-18 2015-08-27 Henkin Robert I Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
CN105963250A (zh) * 2016-06-21 2016-09-28 俞力 一种口服葡萄糖溶液及其制备方法
AU2020402994A1 (en) * 2019-12-11 2022-06-23 Inspirna, Inc. Methods of treating cancer
KR102615692B1 (ko) * 2021-10-13 2023-12-19 주식회사 휴엔켐 베타-구아니디노프로피온산을 포함하는 간섬유화 예방 또는 치료용 조성물
KR102822799B1 (ko) 2022-11-09 2025-06-20 충남대학교산학협력단 베타-구아니디노프로피온산을 포함하는 장내 미생물 개선용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA891509A (en) * 1972-01-25 Beecham Group Limited Esters and amides of guanidine aliphatic acids
GB1153424A (en) * 1965-04-15 1969-05-29 Horlicks Ltd Pharmaceutical Compositions
GB1195199A (en) * 1966-11-25 1970-06-17 Horlicks Pharmaceuticals Ltd Improvements in Compositions comprising Insulin.
GB1195200A (en) * 1967-02-07 1970-06-17 Horlicks Pharmaceuticals Ltd Pharmaceutical Compositions.
US3843798A (en) * 1973-03-12 1974-10-22 Stanley Drug Products Inc Methods and compositions for inducing resistance to bacterial infections
GB1552179A (en) * 1976-11-02 1979-09-12 Beecham Group Ltd Pharmaceutical compositions for treating hyperglycaemia
WO1993003724A1 (en) * 1991-08-26 1993-03-04 The Upjohn Company Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride

Also Published As

Publication number Publication date
AU7485091A (en) 1991-09-18
NZ237249A (en) 1994-09-27
WO1991012799A1 (en) 1991-09-05
ZA911496B (en) 1991-12-24
AU7316591A (en) 1991-09-18
EP0713699A3 (enExample) 1996-07-10
JPH05505189A (ja) 1993-08-05
CA2073873A1 (en) 1991-08-29
DE69121561D1 (de) 1996-09-26
US5134164A (en) 1992-07-28
DE69121561T2 (de) 1997-01-30
AU645076B2 (en) 1994-01-06
EP0517820B1 (en) 1996-08-21
ES2090317T3 (es) 1996-10-16
WO1991012800A1 (en) 1991-09-05
ATE141505T1 (de) 1996-09-15
JP2637712B2 (ja) 1997-08-06
EP0713699A2 (en) 1996-05-29
EP0517820A1 (en) 1992-12-16
GR3021424T3 (en) 1997-01-31
CA2073873C (en) 1996-10-29
JPH0825875B2 (ja) 1996-03-13
US5132324A (en) 1992-07-21
NZ245541A (en) 1997-05-26
KR100190257B1 (ko) 1999-06-01
JPH0820534A (ja) 1996-01-23

Similar Documents

Publication Publication Date Title
DK0517820T3 (da) Anvendelse af 3-guanidinopropionsyre ved fremstillingen af et lægemiddel til behandling og hindring af overdreven fedme
DK0751709T3 (da) Anvendelse af Bcl-2 til fremstilling af lægemidler til terapeutisk behandling og forebyggelse af sygdomme
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
DK0927024T3 (da) Indretning og fremgangsmåde til behandling af öjensygdomme
DK0547952T3 (da) Anvendelse af modafinil til fremstilling af et antiisskæmisk lægemiddel
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
DK0707487T3 (da) Fremgangsmåder og farmaceutiske præparater, der er nyttige til behandling af neurologiske lidelser
GR20010300006T1 (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
FI945426A7 (fi) GABA- ja L-glutamiinihappoanalogit kohtauksenvastaiseen käsittelyyn
FI955782L (fi) Menetelmä kivun käsittelemiseksi 24-tunnin suun kautta annettavia opioidiformulointeja, joilla saadaan lääkkeen plasmatason nopea alkunousu
DE122005000043I1 (de) Zusammensetzungen zur Erzielung von analgesie und zur Hemmung der Progression neuropatisher Schmerz erkrankungen
DK0664708T3 (da) Metode til behandling af cancer ved kombinationsbehandling med 2'-halogenmethylidenderivater og et S-fase- eller M-fase-spe
DK0687184T3 (da) Rekombinante adenoviruser og anvendelse deraf ved genterapi til behandling af øjensygdomme
NO962752D0 (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
NO944339D0 (no) Melatoninderivater for anvendelse ved behandling av sövnforstyrrelser
LV10839A (lv) Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens
DE3361812D1 (en) Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes
HK1046089A1 (zh) 褪黑激素的治疗用途
NO944340L (no) Melatoninderivater for anvendelse ved behandling av desynkroniseringstilstander
IL126159A (en) Pharmaceutical composition containing duloxetine for treating or preventing interstitial cystitis
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
DE68909750D1 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.
BR9708037A (pt) Método para o tratamento de abuso de substância
DK1235573T3 (da) Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme
EP0182569A3 (en) Use of 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyridoû1,2-a¨pyrimidine-3-carboxamide for the prevention and treatment of gastrointestinal damages